Analysts See $0.21 EPS for Nanometrics (NANO); Kindred Biosciences (KIN) Sellers Increased By 1.28% Their Shorts

Kindred Biosciences Inc (NASDAQ:KIN) had an increase of 1.28% in short interest. KIN’s SI was 426,000 shares in April as released by FINRA. Its up 1.28% from 420,600 shares previously. With 281,200 avg volume, 2 days are for Kindred Biosciences Inc (NASDAQ:KIN)’s short sellers to cover KIN’s short positions. The SI to Kindred Biosciences Inc’s float is 1.64%. The stock increased 1.24% or $0.11 during the last trading session, reaching $8.96. About 38,603 shares traded. Kindred Biosciences, Inc. (NASDAQ:KIN) has risen 22.47% since April 23, 2018 and is uptrending. It has outperformed by 18.10% the S&P500. Some Historical KIN News: 08/05/2018 - Kindred Biosciences 1Q Loss/Shr 36c; 24/04/2018 - Kindred Biosciences: Zimeta IV Is for the Control of Fever in Horses; 07/05/2018 - FDA approves Kindred’s weight-loss ointment for cats; 07/05/2018 - Kindred Biosciences Receives FDA Approval Of Mirataz(TM) (mirtazapine Transdermal Ointment) For The Management Of Weight Loss In Cats; 24/04/2018 - KIN: FDA HAS NO QUESTIONS, REQUESTS FOR ZIMETA IV SUBMISSION; 25/04/2018 - Kindred Biosciences Announces Appointment of Ernest Mario, Joseph McCracken to Board of Directors; 24/04/2018 - Kindred Biosciences: FDA Has No Additional Questions or Requests for Regarding Submission; 24/04/2018 - KIN: FDA SAYS APPROVAL IS PENDING PRE-APPROVAL INSPECTION; 07/05/2018 - KINDRED BIOSCIENCES GETS FDA APPROVAL OF MIRATAZ™ (MIRTAZAPINE; 25/04/2018 - Kindred Biosciences Announces the Appointment of Dr. Ernest Mario and Dr. Joseph McCracken to its Board of Directors

Analysts expect Nanometrics Incorporated (NASDAQ:NANO) to report $0.21 EPS on May, 7.They anticipate $0.46 EPS change or 68.66% from last quarter’s $0.67 EPS. NANO’s profit would be $5.15 million giving it 38.29 P/E if the $0.21 EPS is correct. After having $0.53 EPS previously, Nanometrics Incorporated’s analysts see -60.38% EPS growth. The stock increased 0.53% or $0.17 during the last trading session, reaching $32.16. About 47,415 shares traded. Nanometrics Incorporated (NASDAQ:NANO) has risen 16.61% since April 23, 2018 and is uptrending. It has outperformed by 12.24% the S&P500. Some Historical NANO News: 01/05/2018 - Nanometrics 1Q Rev $82.3M; 14/03/2018 Jim Barnhart Joins Nanometrics as Senior Vice President of Operations; 01/05/2018 - Nanometrics 1Q EPS 67c; 17/04/2018 - Nanometrics Closes Above 50-Day Moving Average: Technicals; 19/03/2018 - Nanometrics Forms Golden Cross: Technicals; 01/05/2018 - Nanometrics Sees 2Q EPS 57c-EPS 74c; 01/05/2018 - Nanometrics Sees 2Q Rev $82M-$90M; 21/04/2018 - DJ Nanometrics Incorporated, Inst Holders, 1Q 2018 (NANO)

Kindred Biosciences, Inc., a biopharmaceutical company, focuses on the development of therapies for pets. The company has market cap of $348.14 million. The company's product pipeline includes small molecules and biologics for a range of indications in dogs, cats, and horses. It currently has negative earnings. The Company’s lead product candidates comprise Zimeta, a dipyrone injection for the control of pyrexia in horses; and Mirataz, a mirtazapine transdermal ointment for the management of weight loss in cats.

Investors sentiment decreased to 1.39 in 2018 Q4. Its down 0.85, from 2.24 in 2018Q3. It dived, as 11 investors sold Kindred Biosciences, Inc. shares while 17 reduced holdings. 11 funds opened positions while 28 raised stakes. 21.29 million shares or 1.68% less from 21.65 million shares in 2018Q3 were reported. Retail Bank Of Montreal Can holds 0% or 479 shares in its portfolio. Northern Corporation accumulated 0% or 372,569 shares. Evanson Asset Management Limited Com reported 0.04% in Kindred Biosciences, Inc. (NASDAQ:KIN). Financial Bank Of America Corporation De has invested 0% in Kindred Biosciences, Inc. (NASDAQ:KIN). Invesco has 98,312 shares for 0% of their portfolio. Moreover, Ariel Invs Ltd Liability Co has 0.3% invested in Kindred Biosciences, Inc. (NASDAQ:KIN) for 2.00 million shares. Citigroup invested 0% in Kindred Biosciences, Inc. (NASDAQ:KIN). Citadel Lc, Illinois-based fund reported 13,453 shares. Charles Schwab Invest Management Inc accumulated 0% or 66,129 shares. 18,500 are held by Alliancebernstein L P. Rhumbline Advisers holds 39,841 shares or 0% of its portfolio. Legal & General Public Limited Co holds 0% in Kindred Biosciences, Inc. (NASDAQ:KIN) or 4,659 shares. Barclays Public Ltd stated it has 0% of its portfolio in Kindred Biosciences, Inc. (NASDAQ:KIN). Tiaa Cref Investment Mgmt Limited Liability Corporation reported 0% in Kindred Biosciences, Inc. (NASDAQ:KIN). California State Teachers Retirement Systems holds 52,329 shares or 0% of its portfolio.

Among 3 analysts covering Kindred Biosciences (NASDAQ:KIN), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Kindred Biosciences had 6 analyst reports since October 31, 2018 according to SRatingsIntel. Cantor Fitzgerald maintained it with “Overweight” rating and $25 target in Wednesday, October 31 report. FBR Capital maintained Kindred Biosciences, Inc. (NASDAQ:KIN) rating on Monday, March 4. FBR Capital has “Buy” rating and $19.25 target. The stock has “Buy” rating by H.C. Wainwright on Thursday, March 7. The stock of Kindred Biosciences, Inc. (NASDAQ:KIN) earned “Buy” rating by Cantor Fitzgerald on Tuesday, March 5.

Since November 1, 2018, it had 1 buying transaction, and 3 selling transactions for $5.51 million activity. Park West Asset Management LLC had bought 741,840 shares worth $7.05 million on Friday, January 18. Chin Richard sold $587,200 worth of Kindred Biosciences, Inc. (NASDAQ:KIN) on Thursday, November 1.

More notable recent Kindred Biosciences, Inc. (NASDAQ:KIN) news were published by: Nasdaq.com which released: “Leading Israeli Cellular Carrier, Pelephone, Launches Siyata Mobile’s UV350 and UR7 - Nasdaq” on April 23, 2019, also Globenewswire.com with their article: “Consolidated Research: 2019 Summary Expectations for ZIOPHARM Oncology, Airgain, Liquidity Services, Kindred Biosciences, Landmark Infrastructure Partners LP, and Sensus Healthcare — Fundamental Analysis, Key Performance Indications - GlobeNewswire” published on April 11, 2019, Nasdaq.com published: “Hong Kong protest leaders vow to continue democracy fight ahead of verdict - Nasdaq” on April 08, 2019. More interesting news about Kindred Biosciences, Inc. (NASDAQ:KIN) were released by: Nasdaq.com and their article: “World Class and Quadron Enter Into Arrangement Agreement - Nasdaq” published on April 16, 2019 as well as Nasdaq.com‘s news article titled: “FinCanna Provides Update on Multi Brand Cannabis Edibles Manufacturer, QVI, of Sonoma County, California - Nasdaq” with publication date: April 18, 2019.

Investors sentiment decreased to 1.37 in 2018 Q4. Its down 0.12, from 1.49 in 2018Q3. It is negative, as 30 investors sold Nanometrics Incorporated shares while 40 reduced holdings. 30 funds opened positions while 66 raised stakes. 20.50 million shares or 6.00% more from 19.34 million shares in 2018Q3 were reported. New York State Common Retirement Fund holds 35,614 shares. Bancorp Of America De has invested 0% of its portfolio in Nanometrics Incorporated (NASDAQ:NANO). Metropolitan Life Insur Co New York accumulated 8,010 shares. The Minnesota-based Ameriprise Fincl has invested 0% in Nanometrics Incorporated (NASDAQ:NANO). Vanguard Grp invested in 1.84 million shares. State Board Of Administration Of Florida Retirement System holds 0% of its portfolio in Nanometrics Incorporated (NASDAQ:NANO) for 23,478 shares. Franklin Res, a California-based fund reported 497,274 shares. Texas Permanent School Fund has 15,847 shares. The Illinois-based Citadel Ltd Liability Com has invested 0% in Nanometrics Incorporated (NASDAQ:NANO). D E Shaw & Company accumulated 54,529 shares. Commonwealth Of Pennsylvania Pub School Empls Retrmt Sys has invested 0% in Nanometrics Incorporated (NASDAQ:NANO). Tower Research Capital Ltd Liability Corp (Trc) stated it has 200 shares or 0% of all its holdings. Numerixs Inv Tech has invested 0.02% of its portfolio in Nanometrics Incorporated (NASDAQ:NANO). Highstreet Asset Management owns 0% invested in Nanometrics Incorporated (NASDAQ:NANO) for 82 shares. Aqr Cap Management Limited Company holds 0% in Nanometrics Incorporated (NASDAQ:NANO) or 83,529 shares.

More notable recent Nanometrics Incorporated (NASDAQ:NANO) news were published by: Nasdaq.com which released: “Earnings Preview: Nanometrics (NANO) Q1 Earnings Expected to Decline - Nasdaq” on April 23, 2019, also Nasdaq.com with their article: “PV Nano Cell Sign Agreement with Allen Woods & Associates for US Sales and Distribution - Nasdaq” published on April 22, 2019, Nasdaq.com published: “C-Bond Systems Awarded Additional US Patent for Increasing Glass Strength - Nasdaq” on April 23, 2019. More interesting news about Nanometrics Incorporated (NASDAQ:NANO) were released by: Nasdaq.com and their article: “Nano Dimension 3D Prints Side-Mounting Technology onto Circuit Boards - Nasdaq” published on April 01, 2019 as well as Nasdaq.com‘s news article titled: “Bruker Consistently Gains From NANO & New Strategic Buyouts - Nasdaq” with publication date: March 27, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.